Lundbeck
HLUN-B.CO
#2432
Rank
HK$47.22 B
Marketcap
HK$49.47
Share price
-0.13%
Change (1 day)
29.83%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): HK$2.77

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is HK$2.75. In 2022 the company made an earnings per share (EPS) of HK$2.09 a decrease over its 2021 EPS that were of HK$4.70.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$2.7732.51%
2022HK$2.09-55.47%
2021HK$4.70-51.83%
2020HK$9.76-28.01%
2019HK$13.56-44.08%
2018HK$24.2451.94%
2017HK$15.96126.64%
2016HK$7.04-120.84%
2015-HK$33.785622.18%
2014-HK$0.59-110.03%
2013HK$5.88-28.08%
2012HK$8.18-52.1%
2011HK$17.08-1.31%
2010HK$17.3115.61%
2009HK$14.97